3rd Quarter - Report

ALKERMES, INC. for ALKERMES, INC.

Firm
Client
Income
—
Expenses
$730,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Maintain six protected classes for depressions and schizophrenia under Medicare Part D; S. 2327 - Seniors Prescription Drug Relief Act H.R. 3 - Elijah E. Cummings Lower Drug Costs Now Act H.R. 19 - Lower Costs, More Cures Act H.R.5260 - Reduced Costs and Continued Cures Act

LobbyistCovered position, as disclosed
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —

Contacted: Natl Institutes of Health (NIH); Substance Abuse & Mental Health Services Administration (SAMHSA); Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); SENATE; Veterans Affairs, Dept of (VA); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP)

Bills named: H.R. 19 (117th), S. 2327 (117th), H.R. 5260 (117th), H.R. 3 (117th)

Health Issues HCR

Awareness of the need for treatment system reform and access to all FDA-approved medications; Support patient-centered care and treatment that ensures comprehensive care and access to all FDA approved treatments; Awareness of outcomes data and the need for training on all medication assisted treatment;

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS U.S. House of Representatives: Rep. Ryan Costello (2015-2018)
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Substance Abuse & Mental Health Services Administration (SAMHSA); Veterans Affairs, Dept of (VA); Health & Human Services, Dept of (HHS); Executive Office of the President (EOP); Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Office of Natl Drug Control Policy (NDCP)

Alcohol and Drug Abuse ALC

Advance the use and funding of FDA-approved medicines to treat addiction in criminal justice and public health settings; H.R.955 - Medicaid Reentry Act of 2021; H.R.1319 - American Rescue Plan Act of 2021 (PL 117-2) H.R.4355, S.2604 - Military Construction, Veterans Affairs, and Related Agencies Appropriations Act, 2022 H.R.4502 - Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R.4372 - Department of the Interior, Environment, and Related Agencies Appropriations Act, 2022 H.R.4505 - Commerce, Justice, Science, and Related Agencies Appropriations Act, 2022

LobbyistCovered position, as disclosed
WILLIAM PATRICK HIBBS U.S. House of Representatives: Rep. Ryan Costello (2015-2018)
MEGAN JACKSON —
ZACHARY MICHAEL MARSHALL U.S. House of Representatives: Rep. Jim Cooper (2008-2014), Rep. John Yarmuth (2014-2019)
PETER NORMAN —

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE; Health & Human Services, Dept of (HHS); Justice, Dept of (DOJ); Office of Natl Drug Control Policy (NDCP); Natl Institutes of Health (NIH); Executive Office of the President (EOP); Substance Abuse & Mental Health Services Administration (SAMHSA)

Bills named: S. 2604 (117th), H.R. 4502 (117th), H.R. 1319 (117th), H.R. 4505 (117th), H.R. 4372 (117th), H.R. 4355 (117th), H.R. 955 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.